Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer.

Onyeisi, Jessica Oyie Sousa; Lopes, Carla Cristina; Götte, Martin

Onyeisi, Jessica Oyie Sousa; Lopes, Carla Cristina; Götte, Martin.

Affiliation

Onyeisi JOS; Department of Gynecology and Obstetrics, University Hospital Münster, Albert-Schweitzer-Campus 1, D11, 48149 Münster, Germany.
Lopes CC; Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil.
Götte M; Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil.

Biomolecules ; 11(4)2021 03 26.

Article in En | MEDLINE | ID: mdl-33810567

Subject(s)

Neoplasms/pathology; Syndecan-4/metabolism; Antineoplastic Agents, Immunological/pharmacology; Antineoplastic Agents, Immunological/therapeutic use; Apoptosis; Cell Adhesion; Extracellular Matrix/metabolism; Gene Expression Regulation, Neoplastic/drug effects; Humans; Neoplasms/drug therapy; Neoplasms/metabolism; RNA Interference; Signal Transduction; Syndecan-4/chemistry; Syndecan-4/genetics

Key words

biomarker; cancer; heparan sulfate; metastasis; prognosis; proteoglycan; signal transduction; syndecan-4

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Syndecan-4 / Neoplasms Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Biomolecules Year: 2021 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google